查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2132436

卡介苗市場規模、佔有率和趨勢分析報告：按產品、分銷管道、地區和細分市場預測（2026-2033 年）

BCG Vaccine Market Size, Share & Trends Analysis Report By Product, By Distribution Channel, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

卡介苗市場概況

全球卡介苗市場預計到 2025 年將達到 1.818 億美元，到 2026 年將成長到 1.903 億美元，到 2033 年將達到 2.755 億美元，2026 年至 2033 年的年複合成長率（CAGR）為 5.4%。

到 2025 年，亞太地區主導市場，佔據 47.8% 的最大佔有率。該產業的發展得益於卡介苗 (BCG) 疫苗在預防結核病 (TB) 和治療非肌肉層浸潤性膀胱癌方面的持續使用。

在許多結核病負擔中度至重度的國家，特別是亞太地區、非洲和拉丁美洲部分地區，這種疫苗已被納入國家免疫規劃。政府免疫規劃和公共衛生機構的採購持續支撐著市場需求。由於市場上的生產商數量有限，供應取決於產能、監管合規性和品質標準。生產商正在投資改造生產設施並擴大產能，以提高產品供應量。雖然卡介苗的新治療用途研究仍在進行中，但其主要用途仍是預防結核病和治療膀胱癌。國際衛生組織的支持、對結核病控制的持續關注以及公共醫療衛生系統的穩定需求，使得已開發國家和開發中國家的市場都保持繁榮。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章：卡介苗市場：變數、趨勢與範圍

  • 市場譜系展望
  • 市場動態
  • 商業環境分析

第4章：卡介苗市場：依產品分類的業務分析

  • 按產品分類的市場佔有率，2025 年和 2033 年
  • 市場規模、預測與趨勢分析：按產品分類，2021-2033 年
  • 免疫療法 卡介苗
  • 用於治療的卡介苗

第5章：卡介苗市場：依通路分類的業務分析

  • 按分銷管道分類的市場佔有率，2025 年和 2033 年
  • 市場規模、預測與趨勢分析：按分銷管道分類，2021-2033 年
  • 公部門
  • 私部門

第6章：卡介苗市場：區域估算與趨勢分析

  • 2025年及2033年區域市佔率分析
  • 區域市場概覽
  • 市場規模、預測與趨勢分析，2021-2033年
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • UAE
    • 科威特

第7章 競爭情勢

  • 參與企業概況
  • 公司市場分析
  • 公司分類
  • 策略規劃
  • 公司簡介列表
    • Merck & Co., Inc.
    • Serum Institute of India Pvt. Ltd.
    • Japan BCG Laboratory
    • AJ Vaccines A/S
    • China National Biotec Group（CNBG）
    • GreenSignal Bio Pharma Ltd.
    • InterVax Ltd.
    • BioFarma.
    • Biomed-Lublin SA
    • BB-NCIPD Ltd.
Product Code: GVR-4-68040-173-3

BCG Vaccine Market Summary

The global BCG vaccine market size was valued at USD 181.8 million in 2025 and is projected to grow from USD 190.3 million in 2026 to USD 275.5 million by 2033, at a CAGR of 5.4% from 2026 to 2033. Asia Pacific dominated the market, accounting for the largest share of 47.8% in 2025. The industry is supported by the continued use of the Bacillus Calmette-Guerin (BCG) vaccine for tuberculosis (TB) prevention and the treatment of non-muscle invasive bladder cancer.

The vaccine is included in national immunization programs in many countries with a moderate to high TB burden, especially across Asia Pacific, Africa, and parts of Latin America. Government vaccination programs and procurement by public health agencies continue to support market demand. The market has a limited number of manufacturers, making supply dependent on production capacity, regulatory compliance, and quality standards. Manufacturers are investing in production upgrades and capacity expansion to improve product availability. Research on new therapeutic uses of BCG is ongoing, but its primary use remains TB prevention and bladder cancer treatment. Support from global health organizations, continued focus on tuberculosis control, and stable demand from public healthcare systems continue to maintain the market across developed and developing countries.

Global BCG Vaccine Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global BCG vaccine market report based on product, distribution channel, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Immune BCG Vaccine
  • Therapeutic BCG Vaccine
  • Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
  • Public Sector
  • Private Sector
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Distribution Channel
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. BCG Vaccine Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis
    • 3.3.3. Pipeline Analysis
    • 3.3.4. Patent Expiry Analysis
    • 3.3.5. Pricing Analysis

Chapter 4. BCG Vaccine Market: Product Business Analysis

  • 4.1. Product Market Share, 2025 & 2033
  • 4.2. Product Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 4.4. Immune BCG Vaccine
    • 4.4.1. Immune BCG Vaccine Market, 2021 - 2033 (USD Million)
  • 4.5. Therapeutic BCG Vaccine
    • 4.5.1. Therapeutic BCG Vaccine Market, 2021 - 2033 (USD Million)

Chapter 5. BCG Vaccine Market: Distribution Channel Business Analysis

  • 5.1. Distribution Channel Market Share, 2025 & 2033
  • 5.2. Distribution Channel Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Million)
  • 5.4. Public Sector
    • 5.4.1. Public Sector Market, 2021 - 2033 (USD Million)
  • 5.5. Private Sector
    • 5.5.1. Private Sector Market, 2021 - 2033 (USD Million)

Chapter 6. BCG Vaccine Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2025 & 2033
  • 6.2. Regional Market Dashboard
  • 6.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
  • 6.4. North America
    • 6.4.1. North America BCG Vaccine Market Estimates and Forecasts, By Country, 2021 - 2033 (USD Million)
    • 6.4.2. U.S.
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Target Disease Prevalence
      • 6.4.2.3. Regulatory Framework
      • 6.4.2.4. Reimbursement Framework
      • 6.4.2.5. U.S. BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.3. Canada
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Target Disease Prevalence
      • 6.4.3.3. Regulatory Framework
      • 6.4.3.4. Reimbursement Framework
      • 6.4.3.5. Canada BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.4. Mexico
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Target Disease Prevalence
      • 6.4.4.3. Regulatory Framework
      • 6.4.4.4. Reimbursement Framework
      • 6.4.4.5. Mexico BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Europe
    • 6.5.1. Europe BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.2. UK
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Target Disease Prevalence
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. Reimbursement Framework
      • 6.5.2.5. UK BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.3. Germany
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Target Disease Prevalence
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. Reimbursement Framework
      • 6.5.3.5. Germany BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.4. France
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Target Disease Prevalence
      • 6.5.4.3. Regulatory Framework
      • 6.5.4.4. Reimbursement Framework
      • 6.5.4.5. France BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.5. Italy
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Target Disease Prevalence
      • 6.5.5.3. Regulatory Framework
      • 6.5.5.4. Reimbursement Framework
      • 6.5.5.5. Italy BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.6. Spain
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Target Disease Prevalence
      • 6.5.6.3. Regulatory Framework
      • 6.5.6.4. Reimbursement Framework
      • 6.5.6.5. Spain BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.7. Denmark
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Target Disease Prevalence
      • 6.5.7.3. Regulatory Framework
      • 6.5.7.4. Reimbursement Framework
      • 6.5.7.5. Denmark BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.8. Sweden
      • 6.5.8.1. Key Country Dynamics
      • 6.5.8.2. Target Disease Prevalence
      • 6.5.8.3. Regulatory Framework
      • 6.5.8.4. Reimbursement Framework
      • 6.5.8.5. Sweden BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.9. Norway
      • 6.5.9.1. Key Country Dynamics
      • 6.5.9.2. Target Disease Prevalence
      • 6.5.9.3. Regulatory Framework
      • 6.5.9.4. Reimbursement Framework
      • 6.5.9.5. Norway BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.2. Japan
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Target Disease Prevalence
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. Reimbursement Framework
      • 6.6.2.5. Japan BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.3. China
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Target Disease Prevalence
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. Reimbursement Framework
      • 6.6.3.5. China BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.4. India
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Target Disease Prevalence
      • 6.6.4.3. Regulatory Framework
      • 6.6.4.4. Reimbursement Framework
      • 6.6.4.5. India BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.5. Australia
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Target Disease Prevalence
      • 6.6.5.3. Regulatory Framework
      • 6.6.5.4. Reimbursement Framework
      • 6.6.5.5. Australia BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.6. South Korea
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Target Disease Prevalence
      • 6.6.6.3. Regulatory Framework
      • 6.6.6.4. Reimbursement Framework
      • 6.6.6.5. South Korea BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.7. Thailand
      • 6.6.7.1. Key Country Dynamics
      • 6.6.7.2. Target Disease Prevalence
      • 6.6.7.3. Regulatory Framework
      • 6.6.7.4. Reimbursement Framework
      • 6.6.7.5. Thailand BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Latin America BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.7.2. Brazil
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Target Disease Prevalence
      • 6.7.2.3. Regulatory Framework
      • 6.7.2.4. Reimbursement Framework
      • 6.7.2.5. Brazil BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.7.3. Argentina
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Target Disease Prevalence
      • 6.7.3.3. Regulatory Framework
      • 6.7.3.4. Reimbursement Framework
      • 6.7.3.5. Argentina BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8. Middle East and Africa
    • 6.8.1. Middle East and Africa BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.2. South Africa
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Target Disease Prevalence
      • 6.8.2.3. Regulatory Framework
      • 6.8.2.4. Reimbursement Framework
      • 6.8.2.5. South Africa BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. Target Disease Prevalence
      • 6.8.3.3. Regulatory Framework
      • 6.8.3.4. Reimbursement Framework
      • 6.8.3.5. Saudi Arabia BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.4. UAE
      • 6.8.4.1. Key Country Dynamics
      • 6.8.4.2. Target Disease Prevalence
      • 6.8.4.3. Regulatory Framework
      • 6.8.4.4. Reimbursement Framework
      • 6.8.4.5. UAE BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.5. Kuwait
      • 6.8.5.1. Key Country Dynamics
      • 6.8.5.2. Target Disease Prevalence
      • 6.8.5.3. Regulatory Framework
      • 6.8.5.4. Reimbursement Framework
      • 6.8.5.5. Kuwait BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Participant Overview
  • 7.2. Company Market Position Analysis
  • 7.3. Company Categorization
  • 7.4. Strategy Mapping
  • 7.5. Company Profiles/Listing
    • 7.5.1. Merck & Co., Inc.
      • 7.5.1.1. Overview
      • 7.5.1.2. Financial Performance
      • 7.5.1.3. Product Benchmarking
      • 7.5.1.4. Strategic Initiatives
    • 7.5.2. Serum Institute of India Pvt. Ltd.
      • 7.5.2.1. Overview
      • 7.5.2.2. Financial Performance
      • 7.5.2.3. Product Benchmarking
      • 7.5.2.4. Strategic Initiatives
    • 7.5.3. Japan BCG Laboratory
      • 7.5.3.1. Overview
      • 7.5.3.2. Financial Performance
      • 7.5.3.3. Product Benchmarking
      • 7.5.3.4. Strategic Initiatives
    • 7.5.4. AJ Vaccines A/S
      • 7.5.4.1. Overview
      • 7.5.4.2. Financial Performance
      • 7.5.4.3. Product Benchmarking
      • 7.5.4.4. Strategic Initiatives
    • 7.5.5. China National Biotec Group (CNBG)
      • 7.5.5.1. Overview
      • 7.5.5.2. Financial Performance
      • 7.5.5.3. Product Benchmarking
      • 7.5.5.4. Strategic Initiatives
    • 7.5.6. GreenSignal Bio Pharma Ltd.
      • 7.5.6.1. Overview
      • 7.5.6.2. Financial Performance
      • 7.5.6.3. Product Benchmarking
      • 7.5.6.4. Strategic Initiatives
    • 7.5.7. InterVax Ltd.
      • 7.5.7.1. Overview
      • 7.5.7.2. Financial Performance
      • 7.5.7.3. Product Benchmarking
      • 7.5.7.4. Strategic Initiatives
    • 7.5.8. BioFarma.
      • 7.5.8.1. Overview
      • 7.5.8.2. Financial Performance
      • 7.5.8.3. Product Benchmarking
      • 7.5.8.4. Strategic Initiatives
    • 7.5.9. Biomed-Lublin S.A.
      • 7.5.9.1. Overview
      • 7.5.9.2. Financial Performance
      • 7.5.9.3. Product Benchmarking
      • 7.5.9.4. Strategic Initiatives
    • 7.5.10. BB-NCIPD Ltd.
      • 7.5.10.1. Overview
      • 7.5.10.2. Financial Performance
      • 7.5.10.3. Product Benchmarking
      • 7.5.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global BCG vaccine market, by region, 2021 - 2033 (USD Million)
  • Table 4 Global BCG vaccine market, by product, 2021 - 2033 (USD Million)
  • Table 5 Global BCG vaccine market, by distibution channel, 2021 - 2033 (USD Million)
  • Table 6 North America BCG vaccine market, by country, 2021 - 2033 (USD Million)
  • Table 7 North America BCG vaccine market, by product, 2021 - 2033 (USD Million)
  • Table 8 North America BCG vaccine market, by distibution channel, 2021 - 2033 (USD Million)
  • Table 9 U.S. BCG vaccine market, by product, 2021 - 2033 (USD Million)
  • Table 10 U.S. BCG vaccine market, by distibution channel, 2021 - 2033 (USD Million)
  • Table 11 Canada BCG vaccine market, by product, 2021 - 2033 (USD Million)
  • Table 12 Canada BCG vaccine market, by distibution channel, 2021 - 2033 (USD Million)
  • Table 13 Mexico BCG vaccine market, by product, 2021 - 2033 (USD Million)
  • Table 14 Mexico BCG vaccine market, by distibution channel, 2021 - 2033 (USD Million)
  • Table 15 Europe BCG vaccine market, by country, 2021 - 2033 (USD Million)
  • Table 16 Europe BCG vaccine market, by product, 2021 - 2033 (USD Million)
  • Table 17 Europe BCG vaccine market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 18 UK BCG vaccine market, by product, 2021 - 2033 (USD Million)
  • Table 19 UK BCG vaccine market, by distibution channel, 2021 - 2033 (USD Million)
  • Table 20 Germany BCG vaccine market, by product, 2021 - 2033 (USD Million)
  • Table 21 Germany BCG vaccine market, by distibution channel, 2021 - 2033 (USD Million)
  • Table 22 France BCG vaccine market, by product, 2021 - 2033 (USD Million)
  • Table 23 France BCG vaccine market, by distibution channel, 2021 - 2033 (USD Million)
  • Table 24 Italy BCG vaccine market, by product, 2021 - 2033 (USD Million)
  • Table 25 Italy BCG vaccine market, by distibution channel, 2021 - 2033 (USD Million)
  • Table 26 Spain BCG vaccine market, by product, 2021 - 2033 (USD Million)
  • Table 27 Spain BCG vaccine market, by distibution channel, 2021 - 2033 (USD Million)
  • Table 28 Norway BCG vaccine market, by product, 2021 - 2033 (USD Million)
  • Table 29 Norway BCG vaccine market, by distibution channel, 2021 - 2033 (USD Million)
  • Table 30 Denmark BCG vaccine market, by product, 2021 - 2033 (USD Million)
  • Table 31 Denmark BCG vaccine market, by distibution channel, 2021 - 2033 (USD Million)
  • Table 32 Sweden BCG vaccine market, by product, 2021 - 2033 (USD Million)
  • Table 33 Sweden BCG vaccine market, by distibution channel, 2021 - 2033 (USD Million)
  • Table 34 Asia Pacific BCG vaccine market, by country, 2021 - 2033 (USD Million)
  • Table 35 Asia Pacific BCG vaccine market, by product, 2021 - 2033 (USD Million)
  • Table 36 Asia Pacific BCG vaccine market, by distibution channel, 2021 - 2033 (USD Million)
  • Table 37 Japan BCG vaccine market, by product, 2021 - 2033 (USD Million)
  • Table 38 Japan BCG vaccine market, by distibution channel, 2021 - 2033 (USD Million)
  • Table 39 China BCG vaccine market, by product, 2021 - 2033 (USD Million)
  • Table 40 China BCG vaccine market, by distibution channel, 2021 - 2033 (USD Million)
  • Table 41 India BCG vaccine market, by product, 2021 - 2033 (USD Million)
  • Table 42 India BCG vaccine market, by distibution channel, 2021 - 2033 (USD Million)
  • Table 43 Australia BCG vaccine market, by product, 2021 - 2033 (USD Million)
  • Table 44 Australia BCG vaccine market, by distibution channel, 2021 - 2033 (USD Million)
  • Table 45 South Korea BCG vaccine market, by product, 2021 - 2033 (USD Million)
  • Table 46 South Korea BCG vaccine market, by distibution channel, 2021 - 2033 (USD Million)
  • Table 47 Thailand BCG vaccine market, by product, 2021 - 2033 (USD Million)
  • Table 48 Thailand BCG vaccine market, by distibution channel, 2021 - 2033 (USD Million)
  • Table 49 Latin America BCG vaccine market, by country, 2021 - 2033 (USD Million)
  • Table 50 Latin America BCG vaccine market, by product, 2021 - 2033 (USD Million)
  • Table 51 Latin America BCG vaccine market, by distibution channel, 2021 - 2033 (USD Million)
  • Table 52 Brazil BCG vaccine market, by product, 2021 - 2033 (USD Million)
  • Table 53 Brazil BCG vaccine market, by distibution channel, 2021 - 2033 (USD Million)
  • Table 54 Argentina BCG vaccine market, by product, 2021 - 2033 (USD Million)
  • Table 55 Argentina BCG vaccine market, by distibution channel, 2021 - 2033 (USD Million)
  • Table 56 Middle East & Africa BCG vaccine market, by country, 2021 - 2033 (USD Million)
  • Table 57 Middle East & Africa BCG vaccine market, by product, 2021 - 2033 (USD Million)
  • Table 58 Middle East & Africa BCG vaccine market, by distibution channel, 2021 - 2033 (USD Million)
  • Table 59 South Africa BCG vaccine market, by product, 2021 - 2033 (USD Million)
  • Table 60 South Africa BCG vaccine market, by distibution channel, 2021 - 2033 (USD Million)
  • Table 61 Saudi Arabia BCG vaccine market, by product, 2021 - 2033 (USD Million)
  • Table 62 Saudi Arabia BCG vaccine market, by distibution channel, 2021 - 2033 (USD Million)
  • Table 63 UAE BCG vaccine market, by product, 2021 - 2033 (USD Million)
  • Table 64 UAE BCG vaccine market, by distibution channel, 2021 - 2033 (USD Million)
  • Table 65 Kuwait BCG vaccine market, by product, 2021 - 2033 (USD Million)
  • Table 66 Kuwait BCG vaccine market, by distibution channel, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 BCG vaccine market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Competitive landscape
  • Fig. 10 BCG vaccine market dynamics
  • Fig. 11 BCG vaccine market: Porter's five forces analysis
  • Fig. 12 BCG vaccine market: PESTLE analysis
  • Fig. 13 Product market, 2021 - 2033 (USD Million)
  • Fig. 14 Immune BCG vaccine market, 2021 - 2033 (USD Million)
  • Fig. 15 Therapeutic BCG vaccine market, 2021 - 2033 (USD Million)
  • Fig. 16 Distribution Channel market, 2021 - 2033 (USD Million)
  • Fig. 17 Public sector market, 2021 - 2033 (USD Million)
  • Fig. 18 Private sector market, 2021 - 2033 (USD Million)
  • Fig. 19 BCG vaccine market revenue, by region
  • Fig. 20 Regional marketplace: Key takeaways
  • Fig. 21 North America BCG vaccine market, 2021 - 2033 (USD Million)
  • Fig. 22 U.S. country dynamics
  • Fig. 23 U.S. BCG vaccine market, 2021 - 2033 (USD Million)
  • Fig. 24 Canada country dynamics
  • Fig. 25 Canada BCG vaccine market, 2021 - 2033 (USD Million)
  • Fig. 26 Mexico country dynamics
  • Fig. 27 Mexico BCG vaccine market, 2021 - 2033 (USD Million)
  • Fig. 28 Europe BCG vaccine market, 2021 - 2033 (USD Million)
  • Fig. 29 UK country dynamics
  • Fig. 30 UK BCG vaccine market, 2021 - 2033 (USD Million)
  • Fig. 31 Germany country dynamics
  • Fig. 32 Germany BCG vaccine market, 2021 - 2033 (USD Million)
  • Fig. 33 France country dynamics
  • Fig. 34 France BCG vaccine market, 2021 - 2033 (USD Million)
  • Fig. 35 Italy country dynamics
  • Fig. 36 Italy BCG vaccine market, 2021 - 2033 (USD Million)
  • Fig. 37 Spain country dynamics
  • Fig. 38 Spain BCG vaccine market, 2021 - 2033 (USD Million)
  • Fig. 39 Norway country dynamics
  • Fig. 40 Norway BCG vaccine market, 2021 - 2033 (USD Million)
  • Fig. 41 Sweden country dynamics
  • Fig. 42 Sweden BCG vaccine market, 2021 - 2033 (USD Million)
  • Fig. 43 Denmark country dynamics
  • Fig. 44 Denmark BCG vaccine market, 2021 - 2033 (USD Million)
  • Fig. 45 Asia Pacific BCG vaccine market, 2021 - 2033 (USD Million)
  • Fig. 46 Japan country dynamics
  • Fig. 47 Japan BCG vaccine market, 2021 - 2033 (USD Million)
  • Fig. 48 China country dynamics
  • Fig. 49 China BCG vaccine market, 2021 - 2033 (USD Million)
  • Fig. 50 India country dynamics
  • Fig. 51 India BCG vaccine market, 2021 - 2033 (USD Million)
  • Fig. 52 Australia country dynamics
  • Fig. 53 Australia BCG vaccine market, 2021 - 2033 (USD Million)
  • Fig. 54 South Korea country dynamics
  • Fig. 55 South Korea BCG vaccine market, 2021 - 2033 (USD Million)
  • Fig. 56 Thailand country dynamics
  • Fig. 57 Thailand BCG vaccine market, 2021 - 2033 (USD Million)
  • Fig. 58 Latin America BCG vaccine market, 2021 - 2033 (USD Million)
  • Fig. 59 Brazil country dynamics
  • Fig. 60 Brazil BCG vaccine market, 2021 - 2033 (USD Million)
  • Fig. 61 Argentina country dynamics
  • Fig. 62 Argentina BCG vaccine market, 2021 - 2033 (USD Million)
  • Fig. 63 MEA BCG vaccine market, 2021 - 2033 (USD Million)
  • Fig. 64 South Africa country dynamics
  • Fig. 65 South Africa BCG vaccine market, 2021 - 2033 (USD Million)
  • Fig. 66 Saudi Arabia country dynamics
  • Fig. 67 Saudi Arabia BCG vaccine market, 2021 - 2033 (USD Million)
  • Fig. 68 UAE country dynamics
  • Fig. 69 UAE BCG vaccine market, 2021 - 2033 (USD Million)
  • Fig. 70 Kuwait country dynamics
  • Fig. 71 Kuwait BCG vaccine market, 2021 - 2033 (USD Million)
  • Fig. 72 Company categorization
  • Fig. 73 Company market position analysis
  • Fig. 74 Strategic framework